Compare Stocks: IONS vs. PRAX vs. AXSM vs. ABVX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IONSPRAXAXSMABVX
Market Snapshot
Current market context for the selected companies.
IONS
$62.94
Market Cap
$10.53B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
PRAX
$370.41
Market Cap
$10.54B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
AXSM
$205.01
Market Cap
$10.85B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
ABVX
$115.44
Market Cap
10.17B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
Performance
Absolute returns and relative performance versus SPY.
| Metric | IONS | PRAX | AXSM | ABVX |
|---|---|---|---|---|
| 1 Month | +16.5% | +27.3% | -9.9% | -2.9% |
| 1 Month vs SPY | +10.6% | +21.5% | -15.7% | -8.7% |
| 3 Months | -18.6% | +5.0% | -11.9% | -10.9% |
| 3 Months vs SPY | -20.9% | +2.8% | -14.2% | -13.2% |
| 6 Months | -21.9% | +8.8% | +25.6% | -3.4% |
| 6 Months vs SPY | -33.9% | -3.2% | +13.6% | -15.4% |
| 1 Year | +49.2% | +673.3% | +69.2% | +44.8% |
| 1 Year vs SPY | +29.6% | +653.7% | +49.6% | +25.2% |
| 2 Years | +32.4% | +644.4% | +135.4% | +890.0% |
| 2 Years vs SPY | -6.4% | +605.6% | +96.6% | +851.2% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.